Epidemiology of Glioma

作者: Jimmy T.

DOI: 10.5772/21698

关键词: Mixed GliomaEpendymomaGliomaOligodendrogliomaTemporal lobeOccipital lobeMedicineOligoastrocytomaPathologyAstrocytoma

摘要: Giomas constitute a broad class of neuroectodermal tumours believed to originate from sustentacular neuroglial cells (Kleihues and Cavenee 2000). Astrocytomas form the largest group gliomas (>75%) glioblastoma multiforme (GBM) is most common type astrocytoma (CBTRUS 2011). Gliomas that share histologic characteristics with ependymal or oligodendrocyte are named ependymomas oligodendrogliomas, but may not necessarily aforementioned cell types Mixed include those which consist more than one glia type. For example, oligodendroglial (as defined by some neuropathologists) GBM an oligodendroglioma component generally have significantly worse clinical outcome overall (Louis et al 2007). Another mixed glioma oligoastrocytoma, contains both astrocyte cells. The Third Edition International Classification Diseases for oncology (ICD-O-3) widely used categorize histology (e.g., malignant glioma=9380, ependymoma NOS=9391, astrocytoma=9430, NOS=9440, NOS=9450) (Fritz Furthermore, grouped site in ICD-O-3 system using Ccodes cerebrum=C71.0, frontal lobal=C71.1, temporal lobe=C71.2, parietal lobe=C71.3, occipital lobe=C71.4, ventricle=C71.5, cerebellum=C71.6, spinal cord=C72.0). World Health Organization (WHO) also has developed classification index grades disease prognosis (I=best IV=worst) (Kliehues 1993). Recent additions “WHO Tumours” Grade I angiocentric (predominantly occurring children young adults fronto-parietal cortex, lobe, hippocampal region), II – pilomyxoid (typically infants hypothalamic/chiasmatic region) Additionally, WHO recognized divergent pattern small characterized EGFR amplification, p16INK4a homozygous deletion, PTEN mutations, LOH 10q

参考文章(142)
S. T. Remes, K. Iivanainen, H. Koskela, J. Pekkanen, Which factors explain the lower prevalence of atopy amongst farmers' children? Clinical & Experimental Allergy. ,vol. 33, pp. 427- 434 ,(2003) , 10.1046/J.1365-2222.2003.01566.X
Andrew E Grulich, Xinan Wan, Matthew G Law, Marylon Coates, John M Kaldor, None, Risk of cancer in people with AIDS. AIDS. ,vol. 13, pp. 839- 843 ,(1999) , 10.1097/00002030-199905070-00014
Jen-Ho Tseng, Edwin Merchant, Ming-Yuan Tseng, Effects of socioeconomic and geographic variations on survival for adult glioma in England and Wales. Surgical Neurology. ,vol. 66, pp. 258- 263 ,(2006) , 10.1016/J.SURNEU.2006.03.048
Hiroko Ohgaki, Paul Kleihues, Epidemiology and etiology of gliomas Acta Neuropathologica. ,vol. 109, pp. 93- 108 ,(2005) , 10.1007/S00401-005-0991-Y
K. Jaffa, M. Herz, Measuring ELF fields produced by mobile phones and personal digital assistants (PDAs) Bioelectromagnetics. ,vol. 28, pp. 583- 584 ,(2007) , 10.1002/BEM.20349
Brigitte Schlehofer, Maria Blettner, Susan Preston-Martin, Dorothea Niehoff, J�rgen Wahrendorf, Annie Arslan, Anders Ahlbom, Won N. Choi, Graham G. Giles, Geoffrey R. Howe, Julian Little, Francois M�n�goz, Philip Ryan, Role of medical history in brain tumour development. Results from the international adult brain tumour study. International Journal of Cancer. ,vol. 82, pp. 155- 160 ,(1999) , 10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P
Vincent Foulongne, Natalie Brieu, Eric Jeziorski, Amandine Chatain, Michel Rodière, Michel Segondy, KI and WU polyomaviruses in children, France. Emerging Infectious Diseases. ,vol. 14, pp. 523- 525 ,(2008) , 10.3201/EID1403.071206
James L. Fisher, Judith A. Schwartzbaum, Margaret Wrensch, Joseph L. Wiemels, Epidemiology of brain tumors Neurologic Clinics. ,vol. 25, pp. 867- 890 ,(2007) , 10.1016/J.NCL.2007.07.002
W. London, S. Houff, D. Madden, D. Fuccillo, M Gravell, W. Wallen, A. Palmer, J. Sever, B. Padgett, D. Walker, G. ZuRhein, T Ohashi, Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus) Science. ,vol. 201, pp. 1246- 1249 ,(1978) , 10.1126/SCIENCE.211583
H Okada, L Villa, J Attanucci, M Erff, WK Fellows, MT Lotze, IF Pollack, WH Chambers, Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells. Gene Therapy. ,vol. 8, pp. 1157- 1166 ,(2001) , 10.1038/SJ.GT.3301496